Takeda Pushes Back as Group Seeks to Stop Shire Purchase

(Bloomberg) -- Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the Japanese drugmaker’s acquisition of Shire Plc, sayin...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.